Antiangiogenic and antitumor effects of 14-membered ring macrolides on mouse B16 melanoma cells

Clinical and Experimental Metastasis

Volumn 17, Issue 4, 1999, Pages 361-367

  Yatsunami, Jun ^a   Fukuno, Yuji ^a   Nagata, Masaki ^a   Tominaga, Masaki ^a   Aoki, Shigehisa ^a   Tsuruta, Nobuko ^b   Kawashima, Michihiro ^a   Taniguchi, Shun'ichiro ^c   Hayashi, Shin Ichiro ^a  

^a SAGA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; B16 melanoma; Macrolides; Metastasis

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; JOSAMYCIN; MACROLIDE; ROXITHROMYCIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG STRUCTURE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; TUMOR GROWTH; TUMOR VOLUME;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL DIVISION; ENDOTHELIUM, VASCULAR; MACROLIDES; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS;

EID: 0032868094     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Folkman J. Tumor angiogenesis. In Mendelsohn J, Howley PM, Israel MA, Liotta LA (eds): The Molecular Basis of Cancer. Philadelphia: W.B. Saunders 1995; 206-32.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1955; 1: 27-31.
3. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333: 1757-63.
4. O'Reilly MS, Holmgren L, Shing Y et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-28.
5. O'Reilly MS, Boehm T, Shing Y et al. Endostalin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-85.
6. Karp JE, Broder S. Molecular foundations of cancer: new targets for intervention. Nat Med 1995; 1: 309-20.
7. Agen C, Danesi R, Blandizzi C et al. Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected role. Agents Actions 1993; 38: 85-90.
8. Kadota J, Saito O, Kohno S, Hara K. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993; 147: 153-9.
9. Oishi K, Sonoda F, Kobayashi S et al. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect Immun 1994; 62: 4145-52.
10. Takizawa H, Desaki M, Ohtoshi T et al. Erythromycin suppresses interleukin-6 expression by human epithelial cells: a potential mechanism of its anti-inflammatory action. Biochem Biophys Res Commun 1995; 210: 781-6.
11. Mitsuyama T, Hidaka K, Furuno T, Hara N. Neutrophil-induced endothelial cell damage: inhibition by a 14-membered ring macrolide through the action of nitric oxide. Int Arch Allergy Immunol, 114: 111-5.
12. Yatsunami J, Tsuruta N, Wakamatsu K et al. Clarithromycin is a potent inhibitor of tumor induced angiogenesis. Res Exp Med (Berlin) 1997; 197: 189-97.
13. Yatsunami J, Tsuruta N, Hara N, Hayashi S. Inhibition of tumor-induced angiogenesis by roxithromycin, a 14-membered ring macrolide antibiotic. Cancer Lett 1998; 131: 137-44.
14. Yatsunami J, Tsuruta N, Fukuno Y et al. Inhibitory effects of roxithromycin on tumor angiogene sis, growth and metastasis of mouse B16 melanoma cells. Clin Exp Meatstasis 1999; 17: 119-25.
15. Taniguchi S, Fujiki H, Kobayashi H et al. Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett 1992; 65: 51-4.
16. Yatsunami J, Tsuruta N, Ogata K et al. Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung. Cancer Lett 1997; 120: 101-8.
17. Arenberg DA, Keane MP, DiGiovine B et al. Epithelial-neutrophil activating peptode (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest 1998; 102: 465-72.
18. Neu HC. Antibacterial therapy: problems and promises, part II. Hosp Pract 1990; 25(6): 181-94.
19. Peters DH, Friedel HA, McTavish D. Azithromycin: a review of antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 1992; 44: 750-99.
20. Konno S, Adachi M, Asano K et al. Influence of roxithromycin on cell-mediated immune responses. Life Sci 1992; 51: 107-12.
21. Yoshimura T, Kurita C, Yamazaki F et al. Effects of roxithromycin on proliferation of peripheral blood mononuclear cells and production of lipopolysaccharide-induced cytokines. Biol Pharm Bull 1995; 18: 876-81.
22. Hamada K, Kita E, Sawaki M, Mikasa K, Narita N. Antitumor effect of erythromycin in mice. Chemotherapy 1995; 41: 59-69.
23. Sassa K, Mizushima Y, Fujishita T et al. Therapeutic effect of clarithromycin on a transplanted tumor in rats. Antimicrob Agents Chemother 1999; 43: 67-72.
24. Mikasa K, Sawaki M, Kita E et al. Significant survival benefit to patients with advanced non-small cell lung cancer from treatment with clarithromycin. Chemotherapy 1997; 43: 288-96.
25. Pierce M, Clampton S, Henry D et al. A randomized trial of clarithromycin as prophylaxis against disseminated Mycohacterium avium complex infection in patients with advanced Acquired Immunodefficiency Syndrome. N Engl J Med 1996; 335: 384-91.
26. Jablonowski H, Fatkenheuer G, Youle M et al. Ancillary benefits of Mycobacterium avium-intracellulare complex prophylaxis with clarithromycin in HIV-infected patients. Drugs 1997; 54 (Suppl 2): 16-22.
27. Twardowski P, Gradishar WJ. Clinical trials of antiangiogenic agents. Curr Opin Oncol 1997; 9: 584-9.
28. Tamargo RJ, Bok RA, Brem H. Angiogenesis inhibition by minocycline. Cancer Res 1991; 51: 672-5.
29. Ono M, Kawahara N, Goto D et al. Inhibition of tumor growth and neovascularzation by an anti-gastric ulcer agent, irsogladine. Cancer Res 1996; 56: 1512-6.
30. Volpert OV, Ward WF, Lingen MW et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 1996; 98: 671-9.
31. Shirai T, Sato A, Chida K. Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity. Intern Med 1995; 34: 469-74.